Plus   Neg

ANI Pharmaceuticals, Inc. Q3 adjusted earnings Beat Estimates

ANI Pharmaceuticals, Inc. (ANIP) announced a profit for its third quarter that climbed from the same period last year.

The company's profit totaled $5.04 million, or $0.42 per share. This compares with $4.72 million, or $0.40 per share, in last year's third quarter.

Analysts had expected the company to earn $1.17 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 5.3% to $50.70 million from $48.16 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q3): . vs. . last year.
-EPS (Q3): $1.29 vs. $1.11 last year.
-Analysts Estimate: $1.17
-Revenue (Q3): $50.70 Mln vs. $48.16 Mln last year.

Full year EPS guidance: $4.80 to $5.27
Full year revenue guidance: $195 to $205 Million

For comments and feedback contact: editorial@rttnews.com

Follow RTT